Mark E. Sims's most recent trade in Candel Therapeutics Inc was a trade of 285,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 6, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Candel Therapeutics Inc | Mark E. Sims | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jul 2026 | 285,000 | 285,000 | - | - | Stock Option (Right to Buy) |